Adaptive Biotechnologies
ADPT
ADPT
226 hedge funds and large institutions have $1.18B invested in Adaptive Biotechnologies in 2023 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 85 increasing their positions, 63 reducing their positions, and 22 closing their positions.
Holders
226
Holders Change
+3
Holders Change %
+1.35%
% of All Funds
3.62%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
26
Increased
85
Reduced
63
Closed
22
Calls
$2.73M
Puts
$364K
Net Calls
+$2.37M
Net Calls Change
-$8.85M
Top Buyers
Top Sellers
| 1 |
BG
1
Bellevue Group
Kuesnacht,
Switzerland
|
$0 |
| 2 |
2
Millennium Management
New York
|
$1.13M |
| 3 |
3
Morgan Stanley
New York
|
$6.3M |
| 4 |
4
BlackRock
New York
|
$104M |
| 5 |
SIG
5
Senator Investment Group
New York
|
$4.42M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
251
Nomura Asset Management
Tokyo,
Japan
| – | – | – | – |
|
|
HT
252
HAP Trading
New York
| – | – | – | – |
|